MRI in corticobasal degeneration.

Area of Science:

• Neurology
• Neuroimaging
• Radiology

Background:

• Corticobasal degeneration (CBD) is a progressive neurological disorder.
• It presents with asymmetric motor symptoms and cognitive decline.
• Definitive diagnosis requires post-mortem examination.

Purpose of the Study:

• To evaluate the utility of MRI in detecting asymmetric brain atrophy in suspected CBD cases.
• To assess MRI's role in supporting clinical diagnosis and differential diagnosis.

Main Methods:

• Brain MRI was performed on ten patients with clinical suspicion of CBD.
• MRI scans were reviewed by a radiologist unaware of the clinical presentation side.
• Original MRI reports were also analyzed.

Main Results:

• MRI revealed asymmetric cortical atrophy, predominantly in the posterior frontal and parietal regions, contralateral to clinical symptoms.
• Asymmetry was often missed on initial readings.
• Review of MRI findings confirmed the ability to detect asymmetrical parietal atrophy.

Conclusions:

• MRI can detect asymmetrical parietal atrophy, supporting the clinical diagnosis of corticobasal degeneration.
• Radiologists must be vigilant for subtle asymmetries to aid in diagnosis.
• MRI findings help differentiate CBD from other neurodegenerative conditions.